Studies | EBMT

Top

Study type

Disease

Group

Type of transplant

Text

LATE COMPLICATIONS AFTER AUTOLOGOUS HSCT FOR AUTOIMMUNE DISEASES: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Autoimmune Diseases Working Party (ADWP)

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Principal investigator

Kirill Kirgizov

Post AHSCT (Autologous Hematopoietic Stem Cell Transplantation) management for patients with systemic sclerosis: a prospective, non-interventional approach across Europe (NISSC-2)

Autoimmune Diseases Working Party (ADWP)

Principal investigator

Pr Dominique Farge

Current strategies of cell and gene therapy for solid tumors

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of Stem Cell Treatment

Principal investigator

Paolo Pedrazzoli

Trend and outcome of HSCT in Thalassemia inside the EBMT

Paediatric Diseases Working Party (PDWP)

Type of Stem Cell Treatment

Principal investigator

Baronciani Donatella

Impact of AB0 Incompatibility on HSCT outcome in hemoglobinopathies: A Retrospective Registry Study from the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Paediatric Diseases Working Party (PDWP)

Type of Stem Cell Treatment

Principal investigator

Katharina Kleinschmidt

Outcomes after graft failure of allogeneic hematopoietic stem cell transplantation in patients with SCD

Paediatric Diseases Working Party (PDWP)

Type of Stem Cell Treatment

Principal investigator

Josu de la Fuente

The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for Acute Myeloid Leukemia in Children- A combined CIBMTR and EBMT analysis

Paediatric Diseases Working Party (PDWP)

Principal investigator

Patients who undergo a Stem cell Transplant may be at risk of being admitted to the PICU

Paediatric Diseases Working Party (PDWP)

Type of Stem Cell Treatment

Principal investigator

Myeloablative conditioning for allo-HSCT in pediatric ALL and AML below 2 years

Paediatric Diseases Working Party (PDWP)

Type of Stem Cell Treatment

Principal investigator

André Willasch

Data collection initiative on CART

Cellular Therapy & Immunobiology Working Party (CTIWP)

Principal investigator

Fecal transplant FOR GVHD

Transplant Complications Working Party (TCWP)

Principal investigator

Dr. J. Bilinski

EASIX to predict alloSCT outcome

Transplant Complications Working Party (TCWP)

Principal investigator

Prof. O. Penack